Email this article 
Post a Comment On the issue of preeclampsia screening efficiency
- Authors: Padrul M.M.1, Turova Е.V.1, Trushkov A.G.1
-
Affiliations:
- Ye.A. Vagner Perm State Medical University
- Issue: Vol 42, No 1 (2025)
- Pages: 36-42
- Section: Original studies
- URL: https://journals.rcsi.science/PMJ/article/view/287607
- DOI: https://doi.org/10.17816/pmj42136-42
- ID: 287607
Cite item
Full Text
Abstract
Objective. To analyze the risk factors for the development of preeclampsia and assess their role in predicting this complication on the basis of a retrospective analysis of medical records data.
Materials and methods. A retrospective analysis of the medical records of 55 patients who ended their pregnancy was carried out. The patients were divided into 2 groups: the first group consisted of 33 puerperal women diagnosed with preeclampsia, the second group included 22 patients without hypertensive complications. A comprehensive assessment of clinical and anamnestic risk factors, as well as the data analysis of the comprehensive screening of the first trimester were carried out.
Results. The analysis of the data obtained showed that an increase in the level of average blood pressure in the first trimester is an important risk factor for the development of hypertensive disorders in the second half of pregnancy (p<0.05). The analysis of clinical and anamnestic risk factors revealed that preeclampsia was significantly more common in the first pregnancies , and in patients with a history of antenatal fetal death (p<0.05). According to the results of routine risk calculation in the first trimester using software, a high risk for developing preeclampsia was determined only in 16% of cases of pregnant women from the first group,
Conclusions. Despite the widespread use of comprehensive screening programs for preeclampsia, the problem of predicting it currently remains unsolved. Particular attention should be paid to a multivariate approach based on the assessment of the combination of factors, since no single marker is able to provide high sensitivity screening when isolated.
Full Text
##article.viewOnOriginalSite##About the authors
M. M. Padrul
Ye.A. Vagner Perm State Medical University
Email: elena_turova06@mail.ru
ORCID iD: 0000-0002-6111-5093
DSc (Medicine), Professor, Head of the Department of Obstetrics and Gynecology №1
Russian Federation, PermЕ. V. Turova
Ye.A. Vagner Perm State Medical University
Author for correspondence.
Email: elena_turova06@mail.ru
ORCID iD: 0009-0006-8019-5048
Assistant of the Department of Obstetrics and Gynecology №1
Russian Federation, PermA. G. Trushkov
Ye.A. Vagner Perm State Medical University
Email: elena_turova06@mail.ru
ORCID iD: 0009-0002-6068-8436
Associate Professor of the Department of Obstetrics and Gynecology №2
Russian Federation, PermReferences
- Филиппов О.С., Гусева Е.В. Материнская смертность в Российской Федерации в 2019 г. Проблемы репродукции 2020; 26 (6–2): 8–26. doi: 10.17116/repro2020260628 / Filippov O.S., Guseva E.V. Maternal mortality in the Russian Federation in 2019. Russian Journal of Human Reproduction 2020; 26 (6–2): 8–26. doi: 10.17116/repro2020260628 (in Russian).
- Савельева Г.М., Серов В.Н., Сухих Г.Т. Акушерство и гинекология: Клинические рекомендации. М.: ГЭОТАР-Медиа 2015; 1024. / Savelyeva G.M., Serov V.N., Sukhikh G.T. Obstetrics. National guideline. Moscow: GEOTAR-Media 2015; 1024 (in Russian).
- Турова Е.В., Олина А.А., Садыкова Г.К. Какова частота встречаемости преэклампсии и эклампсии в Пермском крае? Данные официальной статистики. Уральский медицинский журнал 2018; (3): 86–90. doi: 10.25694/URMJ.2018.03.018 / Turova E.V., Olina A.A., Sadykova G.K. What is the frequency of occurrence of preeclampsia and eclampsia in Perm region? Official statistics. Ural Medical Journal 2018; (3): 86–90. doi: 10.25694/URMJ.2018.03.018 (in Russian).
- Сидорова И.С., Никитина Н.А., Филиппов О.С., Гусева Е.В., Агеев М.Б., Кокин А.А. Решенные и нерешенные вопросы преэклампсии по результатам анализа материнской смертности за последние 10 лет. Акушерство и гинекология 2021; 4: 64–74. doi: 10.18565/aig.2021.4.64-74 / Sidorova I.S., Nikitina N.A., Filippov O.S., Guseva E.V., Ageev M.B., Kokin A.A. Current issues in preeclampsia: a ten-year analysis of maternal mortality. Akusherstvo i Ginekologiya/Obstetrics and Gynecology 2021; 4: 64–74. doi: 10.18565/aig.2021.4.64-74 (in Russian).
- Сидорова И.С., Никитина Н.А., Филиппов О.С., Гусева Е.В., Гранатович Н.Н. Состояние материнской смертности от преэклампсии и эклампсии в Российской Федерации в 2014 г. Что меняется в процессе анализа? Российский вестник акушера-гинеколога 2015; 15 (6): 4–11. doi: 10.17116/rosakush20151564-11 / Sidorova I.S., Nikitina N.A., Filippov O.S., Guseva E.V., Granatovich N.N. Maternal mortality from preeclampsia and eclampsia in the Russian Federation in 2014. What changes during an analysis? Russian Bulletin of Obstetrician-Gynecologist 2015; 15 (6): 4–11. doi: 10.17116/rosakush20151564-11 (in Russian).
- Magee L.A., Nicolaides K.H., von Dadelszen P. Preeclampsia. N Engl J Med. 2022 May 12; 386 (19): 1817–1832.
- Wright A., Wright D., Syngelaki A., Georgantis A., Nicolaides K.H. Two-stage screening for preterm preeclampsia at 11–13 weeks' gestation. Am J Obstet Gynecol. 2019 Feb; 220 (2): 197.e1–197.e11. doi: 10.1016/j.ajog.2018.10.092
- Townsend R., Khalil A., Premakumar Y., Allotey J. et al. IPPIC Network. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019; 54 (1): 16–27. doi: 10.1002/uog.20117
- Rolnik D.L., Nicolaides K.H., Poon L.C. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022; 226 (2S): S1108-S1119. doi: 10.1016/j.ajog.2020.08.045
- Wright D., Wright A., Tan M.Y., Nicolaides K.H. When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. Am J Obstet Gynecol. 2022; 226 (2S): S1120-S1125. doi: 10.1016/j.ajog.2021.10.038
Supplementary files
